chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt lost consciousness while seated about a minute or two after the vaccine was given. Syncope lasted about 30 seconds. Pt also urinated while unconscious. Pt laid down with cold compress. Gave 3 lollipops, 3 glasses of water and granola bar. Pt tried to sit up and then stand twice, but continued to be pale, sweaty, and tired. Pt also reported get nauseous feeling. After about an hour and still not feeling well, EMS was called. Pt transported to hospital about 10:20 am. Mother called me about 1:45pm the same day. She reported after observation, pt was sent home from hospital without treatment. She stated patient feels better.
Nov 29/12 = patient took 1st dose Nov 31/12 = patient took 2nd dose} unrefriger Dec 3/12 = Patient took 1st dose 2nd pack. Same day had stomach cramps.
itching; having a rash; This is a spontaneous report from a contactable 65-year-old male consumer reported for himself that he received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number; unknown, unable to locate or read the details) via an unspecified route of administration on 25Jan2021 at 02:00 pm at 1st dose, single on left arm for covid-19 immunisation. Patient was 6years-old at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was reported as Doctor's office/urgent care. Patient's medical history was not reported; Allergies to medications, food, or other products was reported as none that i am aware of. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient's concomitant medications (other medications the patient received within 2 weeks of vaccination) included atorvastatin, metformin and lisinopril (dates, indication and dosage unspecified). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced itching and having a rash starting on 25Jan2021. The reported events were not considered as serious and did not fall under any seriousness criteria. No treatment was received for the adverse events. On follow-up received on 16Apr2021, it was reported that the lot/batch number is not available despite the follow-up attempts made. The outcome of events was not recovered.   Follow-up attempts have been completed and no further information is expected.
Had chills and fever and achy. Woke up on the floor next to my bed and had a lot of trouble getting back in bed. Had fever most of the day and slept most of the day.
Initial and follow-up info has been received from a licensed practical nurse concerning a 13.5 month old male pt with banana allergy who on 05/21/2001 at 14:00 was vaccinated with the first dose in the left leg of varicella vaccine, a first dose of MMR vaccine in the right thigh, a fourth dose in the right leg of Prevnar, a third dose in the left leg of IPOL and a fourth dose in the right leg of Hib-TITER. There were no illnesses at the time of vaccination or other concomitant medications. On 06/11/2001, the  pt presented to the physician's office with a generalized skin rash consistent with mild chicken pox. It was reported that the symptoms began on 06/07/2001. The pt subsequently recovered on an unknown date. No further info is available.
Patient stated pain at moment of injection which became worse over the month following the vaccine.  The pain was such that she had trouble performing tasks at her job.  Patient opted not to see her doctor.  I followed up  with her 6 days later and she felt it was improving.
Right sided sciatic nerve pain developed beginning late April - physician evaluation obtained May5, 2021 Lower back pain began late May, 2021 Right hip pain developed beginning July, 2021
Fever, chills night sweats, belching ang gas, bloating, fluid around heart and lungs
Left ear pain. Developed into plugged ear... Saw primary care/urgent care 4 times. Treated with ear drops and amoxicillin. Just saw ENT. Symptoms not resolved.
Patient received 0.25cc of Moderna for dose 1 instead of 0.5cc
While sitting in observation post vax, at 4:15 PM, pt states that she felt anxious and took her own personal dose of ativan 1 mg. Pt had visual shakes and slight diaphoreses. Assessing RN gave 1 bottle of water. HR 119, 02 sat on RA 99 %. Pt remained anxious, husband at side. After a period of 15 min, pt requested RN to call 911. Charge Nurse notifiedn911 w/ current BP of 190/100 at 4:28 PM. Pt remained alert until arrival of EMS for transport to  Medical Center. Husband remained w/ client for transport. Gave care to EMS at 4:45.
Reported "swollen tongue" with "numbness" to right side of tongue and "slight tingling to my neck that just lasted a minute" that started approximately 30 minutes after administration. Swelling did not impair speech, swallowing, or breathing. Symptoms improved throughout the day.
Onset occurred over 30 minute period.  Began to feel flu like symptoms.  I also experienced swelling in my throat, eyes, and lips.  I also had itchy, watery eyes.  Felt as if I had a temperature, was severely congested, and sudden lack of energy. Took Benadryl after about 45 minutes.  Immediate improvement in swelling.  Other symptoms decreased overnight, with both them and swelling completely ceasing about 24 hours after vaccination.
Patient record; Records show in need of MMR and Varicella ;  patient was given MMRV and is above the age of 12. No adverse event,  just administrated outside of intended age.   Patient brought another record to the clinic that showed that he had an MMR and Varicella in 2012 given but not reported to the statewide system.   Patient was up to date on MMR and Varicella but was given an MMRV on 6/22/22
This spontaneous report as received from a pharmacist refers to a 40 year old male patient. On 10-OCT-2013 the patient was vaccinated with a dose of ZOSTAVAX (lot # J004269, expiration date 02-JUL-2013, dose not reported, subcutaneously) and a dose of FLUVIRIN at two separate injection sites. There was no concomitant medication, pertinent medical history or drug reactions/allergies. Approximately in October 2013 ("over the weekend") the patient experienced an injection site reaction at the site in which he received the ZOSTAVAX. The site of the reaction was "an oval shape (couple of inches), red and more red in the center" and tender. There was no treatment given for the events. No lab diagnostics studies performed. The patient sought medical attention via visited pharmacy. The outcome of the events was reported as recovering. Additional information has been requested.
A consumer report has been received from a website. The report concerns a female patient. The patient's relevant medical history or concomitant medications were not reported. The patient posted on the website that she received FLUMIST QUADRIVALENT (intranasal), four strain H1N1, 0.2 millilitres, unknown frequency in Feb-2014. After receiving the FLUMIST QUADRIVALENT, she developed a brain disorder and became narcoleptic. Indicated, when she laughed body went paralyze like epilepsy. The patient was currently on disability. She also mentioned one of the medications she took blocked her birth control, at the time of the report she was pregnant. Did not specify what other medications she has been taking. Action taken of FLUMIST QUADRIVALENT was unknown. The outcome of the events of brain disorder, when she laughs body paralyzes like epilepsy, narcolepsy and epilepsy was unknown. According to the company physician the event of brain disorder-narcolepsy added separately as brain disorder and narcolepsy and assessed as serious adverse event due to important medical event. According to the company physician the events of when she laughs body paralyzes like epilepsy and epilepsy was considered to be serious with the serious criteria of important medical event.
Dime sized, raised red rash, volar aspect left arm, scattered raised, red pinpoint rash, volar aspect right forearm.  Complained of tightness in chest briefly, resolved approximately 20 minutes after benadryl given.
Tingling in (Right) arm of injection site, burning pain and sensation in right arm from top of shoulder down, prolong bruising of injection site, Small blistering along arm, redness in arm.
ARM SWELLED FROM ELBOW TO NECK RED INFLAMED PAINFUL THE NEXT DAY. TOLD TO ICE AND WATCH IF NOT BETTER SEE DOCTOR. WENT TO DOCTOR AND STARTED ON ABT. 95% BETTER TODAY.
We had a patient today that passed out after his covid vaccine.  It was his 2nd covid immunization.  He got his immunization at the pharmacy in the booth and then he sat down in one of the waiting chairs at the end of the cough and cold aisle.  While he was sitting down, he began to feel unwell, he then got up off his chair and then was approaching the drop off window (he was going to let us know he didn't feel well) at that time he then passed out.  He fell into the privacy screen of the imz booth.  He did fall into the booth which did break some of his fall.  He also knocked off one of the frames that we had on the wall, and then I think it fell on his nose.  He did get a cut nose and he also bit his lip or mouth because his mouth was bleeding also.  He reported that his nose did hurt, and he will have a prominent bruise on his nose.   We did provide him with a couple of ice packs and a bottle of water.   The patient (25 years old) and his mother both stated that he has passed out in the past when he has been around needles.  He stated that he got to thinking about getting the shot and the needle going into his arm and that is when he started to feel unwell.
Caregiver called and sai he suffered from three Ischemic stokes 12 days after recieving the vaccine. Spent a few days in the hospital but recovining with no significant deficiets.
Within 24 Hours of receiving vaccines parents report right sided facial palsy. No other reported symptoms. As of 11/14/2005 3days later symptoms were better but still present. Pt to be seen by neurologist.
Sore arm; Fever; chills; Nausea; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PYREXIA (Fever), CHILLS (chills), NAUSEA (Nausea) and MYALGIA (Body ache) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder (No medical history reported.) and Cholesterol.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), PYREXIA (Fever), CHILLS (chills), NAUSEA (Nausea) and MYALGIA (Body ache). At the time of the report, PAIN IN EXTREMITY (Sore arm), PYREXIA (Fever), CHILLS (chills), NAUSEA (Nausea) and MYALGIA (Body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medication included Thyroid Medication and Cholesterol medication
Developed rash on left arm 9 days after receiving first dose; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Developed rash on left arm 9 days after receiving first dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced RASH (Developed rash on left arm 9 days after receiving first dose). The patient was treated with CETIRIZINE HYDROCHLORIDE (BENADRYL ALLERGY [CETIRIZINE HYDROCHLORIDE]) for Rash, at an unspecified dose and frequency. At the time of the report, RASH (Developed rash on left arm 9 days after receiving first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medications are provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
arm pain; some tiredness; I might have just been nervous; tightness in the back of her throat that lasted for 30 minutes afterward; This is a spontaneous report received from a contactable consumer (patient). A 66-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number and expiry date was not reported), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported.  On an unspecified date, the patient experienced tightness in the back of her throat that lasted for 30 minutes afterward and described it as a feeling like she "had to clear my throat", arm pain, some tiredness, might have just been nervous. Seriousness was reported as no. It was reported that patient calling on behalf of her granddaughter, who is 22 y/o and has read about the Pfizer-Biontech Covid19 vaccine causing infertility. Is this true? Reported that she stated that she doesn't get vaccines very often, and might have just been nerves contributing to the tightness in her throat. Is this something she should mention before getting her second dose? Reminded caller to let vaccination site know of her previous experience, may want to monitor her longer after vaccination. The outcome of event (tightness in the back of her throat that lasted for 30 minutes afterward) was recovered on un unspecified date and outcome of events (arm pain, some tiredness, i might have just been nervous) was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
itching all over/bottom of his feet were itching too/he was scratching all over, his back, legs everywhere; This is a spontaneous report from a contactable consumer (patient). A 53-year-old male patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EK5730), intramuscular in left arm on 18Dec2020 12:45 at single dose for Covid-19 immunisation. Medical history included hypertension and anemia (he only has anemia and hypertension) from 2018 to an unknown date. Concomitant drug included other medications, but he didn't have the list in front of him. Prior vaccinations within 4 weeks was none. He just got the COVID vaccine today (18Dec2020). He started itching about 2 hours ago, once he got home. He was just itching all over. He had a hairbrush just scratching himself because he was itching all over, he was scratching all over, his back, legs everywhere. He confirmed this was his first dose of the COVID vaccine. He was supposed to go back in three weeks to get the second dose. He had not been to an emergency room or physician office yet, but he's getting ready to go. The bottom of his feet were itching too. The itching was everywhere. That was the only symptoms that he had his body was itching. He worked at a hospital, supply them with mask, he was supply technician. He worked closely with may not be the patient everyday. He was on an esophagogastroduodenoscopy (EGD) done where they put tube down through throat and colonoscopy and EGD, they found some information and they removed it, about a month ago. The outcome of event was not recovered.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On 05-JAN-2017 at 15:18, the patient was vaccinated with improperly stored VARIVAX injection (lot # M035142) ( expiration date, dose and route of administration were not reported). The vaccine underwent previous temperature excursions. The number of previous excursions, time frames and values of incorrect temperature were unknown. No adverse effects were reported. Digital data logger was used. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1704USA000406: US-009507513-1704USA000389: US-009507513-1704USA000390: US-009507513-1704USA000391: US-009507513-1704USA000392: US-009507513-1701USA008441: US-009507513-1704USA000394: US-009507513-1704USA000395: US-009507513-1704USA000396: US-009507513-1704USA000397: US-009507513-1704USA000398: US-009507513-1704USA000399: US-009507513-1704USA000400: US-009507513-1704USA000401: US-009507513-1704USA000402: US-009507513-1704USA000403: US-009507513-1704USA000404: US-009507513-1704USA000405: US-009507513-1704USA000407: US-009507513-1704USA000408: US-009507513-1704USA000409: US-009507513-1704USA000410: US-009507513-1704USA000411: US-009507513-1704USA000412: US-009507513-1704USA000413: US-009507513-1704USA000414: US-009507513-1704USA000415: US-009507513-1704USA000416: US-009507513-1704USA000417: US-009507513-1704USA000418: US-009507513-1704USA000419: US-009507513-1704USA000420: US-009507513-1704USA000421: US-009507513-1704USA000422: US-009507513-1704USA000423: US-009507513-1704USA000424: US-009507513-1704USA000425: US-009507513-1704USA000426: US-009507513-1704USA000427: US-009507513-1704USA000428: US-009507513-1704USA000429: US-009507513-1704USA000430: US-009507513-1704USA000431: US-009507513-1704USA000432: US-009507513-1704USA000433: US-009507513-1704USA000434: US-009507513-1704USA000435: US-009507513-1704USA000436: US-009507513-1704USA000437: US-009507513-1704USA000438: US-009507513-1704USA000439: US-009507513-1704USA000440: US-009507513-1704USA000441: US-009507513-1704USA000442: US-009507513-1704USA000443: US-009507513-1704USA000444: US-009507513-1704USA000445: US-009507513-1704USA000446: US-009507513-1704USA000447: US-009507513-1704USA000448: US-009507513-1704USA000449: US-009507513-1704USA000450: US-009507513-1704USA000451: US-009507513-1704USA000452: US-009507513-1704USA000453: US-009507513-1704USA000454: US-009507513-1704USA000455: US-009507513-1704USA000456: US-009507513-1704USA000457
Initial unsolicited report received from a consumer via social media on 10 Oct 2016. This case is linked to 2016SA188144, 2016SA188556, 2016SA188803, 2016SA188804, 2016SA188805, 2016SA188806, 2016SA188807, 2016SA188808, 2016SA188809, 2016SA188810, 2016SA188811, 2016SA188812, 2016SA188813, 2016SA188814, 2016SA188815, 2016SA188816, 2016SA188817, 2016SA188818, 2016SA188819, 2016SA188820, 2016SA188821, 2016SA188822, 2016SA188833, 2016SA188834, 2016SA188835, 2016SA188836, 2016SA188837, 2016SA188838, 2016SA188840, 2016SA188841, 2016SA188842, 2016SA188843, 2016SA188844, 2016SA188845, 2016SA188846, 2016SA188847, 2016SA188848, 2016SA188849, 2016SA188850, 2016SA188851. (Same reporter source, same vaccine). This case involves a male patient (age not reported) who was vaccinated with a dose of Flu shot (batch number, expiry date, dose, dose in series, route and site of administration were not reported) on an unspecified date. The patient's medical history and concomitant medications were not reported. On an unknown date, 30 hours following the vaccination, the patient died. The patient's laboratory data and corrective treatment was not reported. It was unknown that Autopsy was performed. List of documents held by sender: none. Sender's Comments: This is poorly documented case of death 30 hours following influenza vaccination. Time to onset is compatible but detail medical history, any co morbidity, past vaccination history leading to any severe reaction and allergic history is needed to further assess the case. Reported Cause(s) of Death: Death NOS.
Test positive for COVID 17Nov2022; Feeling sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 13Nov2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious) with onset 14Nov2022, outcome "unknown", described as "Feeling sick"; COVID-19 (non-serious) with onset 17Nov2022, outcome "unknown", described as "Test positive for COVID 17Nov2022". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient received the updated COVID-19 booster dose on Sunday, 13Nov2022, then the next day, 14Nov2022, started feeling sick but thought that this was only side effect of the vaccine. The patient tested positive for COVID-19 on 17Nov2022. The patient was just wondering of the shot offers protection if the patient was unknowingly infected when received the vaccine.   The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
This spontaneous report as received from a pharmacist via company representative refers to an unknown number of patients of unknown age. Approximately in 2012 (about one and half years ago) the unknown number of patients were vaccinated with ZOSTAVAX (lot# and dose not reported), subcutaneous, in the "tricep" area of the arms of these patients. The pharmacist reported that the unknown number of patients developed welts on their arms at the injection site after receiving ZOSTAVAX. The outcome of the event was unknown. The patients sought medical attention by unknown method. Additional information has been requested.
REACTION TO COVID-19 VACCINE; CHILLS; FEVER; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received guselkumab (solution for injection in pre-filled pen, route of admin, and batch number were not reported) dose, frequency, and therapy dates were not reported for drug used for unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced reaction to covid-19 vaccine, chills, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and action taken with guselkumab was not reported. The outcome of the fever, chills and reaction to covid-19 vaccine was not reported. This report was non-serious.